
Artios Pharma Announces Details of Presentations at the American Association for Cancer Research (AACR) Annual Meeting ...
CAMBRIDGE, United Kingdom and NEW YORK, April 15, 2025 – Artios Pharma Limited (“Artios”), a clinical-stage biotech company led by pioneers of DNA damage response (“DDR”) drug development, today announced that the company’s abstract featuring clinical …